Offer - Urjas Oil for just ₹ 1 X
Combitide 25 Mcg/125 Mcg Inhaler is a prescription drug, available for use as Inhaler. Combitide 25 Mcg/125 Mcg Inhaler also has some secondary and off-label uses. These are listed below.
The right dosage of Combitide 25 Mcg/125 Mcg Inhaler depends on the age, gender, and medical history of the patient. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. This information has been provided in detail in the dosage section.
Common side effects of Combitide 25 Mcg/125 Mcg Inhaler include Shortness of Breath, Throat Irritation, Nosebleed. Besides the aforementioned side effects, there are other adverse effects of Combitide 25 Mcg/125 Mcg Inhaler as well, which are listed below. Such side effects of Combitide 25 Mcg/125 Mcg Inhaler normally do not last long and go away once the treatment is completed. If, however, they worsen or do not go away, please speak with your physician.
Combitide 25 Mcg/125 Mcg Inhaler's effect during pregnancy is Moderate and Mild while nursing. It is important to know if Combitide 25 Mcg/125 Mcg Inhaler has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Combitide 25 Mcg/125 Mcg Inhaler related warnings section.
Other contraindications of Combitide 25 Mcg/125 Mcg Inhaler have been discussed in the sections ahead.
Drug reaction of Combitide 25 Mcg/125 Mcg Inhaler with other medicines has been reported. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking Combitide 25 Mcg/125 Mcg Inhaler is considered safe while driving, and is addictive.
Combitide 25 Mcg/125 Mcg Inhaler is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
Adult |
|
Geriatric |
|
Is the use of Combitide 25 Mcg/125 Mcg Inhaler safe for pregnant women?
Pregnant women may experience moderate side effects from Combitide. It is best to stop taking Combitide immediately and inform your doctor if you notice any discomfort.
Is the use of Combitide 25 Mcg/125 Mcg Inhaler safe during breastfeeding?
Side effects of Combitide for breastfeeding are little to none, so you can take it without doctor's advice.
What is the effect of Combitide 25 Mcg/125 Mcg Inhaler on the Kidneys?
Combitide is not harmful for kidneys.
What is the effect of Combitide 25 Mcg/125 Mcg Inhaler on the Liver?
You may experience side effects on your liver after taking Combitide. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Combitide 25 Mcg/125 Mcg Inhaler on the Heart?
The heart can be affected by Combitide. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart the medicine only after medical advice.
If you are suffering from any of the following diseases, you should not take Combitide 25 Mcg/125 Mcg Inhaler unless your doctor advises you to do so -
Is this Combitide 25 Mcg/125 Mcg Inhaler habit forming or addictive?
Forming a habit of Combitide 25 Mcg/125 Mcg Inhaler has not been reported.
Interaction between Food and Combitide 25 Mcg/125 Mcg Inhaler
Due to a lack of research, nothing can be said about the consequences of taking Combitide 25 Mcg/125 Mcg Inhaler together with food.
Interaction between Alcohol and Combitide 25 Mcg/125 Mcg Inhaler
It is difficult to say anything about the effect of Combitide 25 Mcg/125 Mcg Inhaler and alcohol. No research has been done on this yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Serevent Diskus (salmeterol xinafoate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 223-224
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1122-1123
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Flonase (fluticasone propionate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 231
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 355-359